Apricus Biosciences Inc. (APRI)

0.41
0.01 2.12
NASDAQ : Health Technology
Prev Close 0.41
Open 0.42
Day Low/High 0.40 / 0.44
52 Wk Low/High 0.25 / 3.34
Volume 206.14K
Avg Volume 1.14M
Exchange NASDAQ
Shares Outstanding 23.44M
Market Cap 10.54M
EPS -1.00
P/E Ratio 1.41
Div & Yield N.A. (N.A)

Latest News

Apricus Biosciences Announces Scheduling Of Vitaros™ End-of-Review Meeting With FDA

Apricus Biosciences Announces Scheduling Of Vitaros™ End-of-Review Meeting With FDA

Meeting Scheduled for April 12, 2018

Apricus Biosciences Receives Complete Response Letter From FDA For Vitaros™

Apricus Biosciences Receives Complete Response Letter From FDA For Vitaros™

Company Evaluating Deficiencies and Potential Path Forward

Apricus Biosciences Announces FDA Acknowledgement Of Vitaros™ Class 2 NDA Resubmission

Apricus Biosciences Announces FDA Acknowledgement Of Vitaros™ Class 2 NDA Resubmission

PDUFA Goal Date of February 17, 2018

Apricus Biosciences Files NDA Resubmission For Vitaros™

Apricus Biosciences Files NDA Resubmission For Vitaros™

Approval Decision Expected in First Quarter 2018

Apricus Biosciences Announces The Initiation Of Vitaros Drug-Device Human Factors Study

Vitaros U.S. NDA Re-Submission on Track for Third Quarter 2017

Apricus Biosciences Announces Approval Of Vitaros® For The Treatment Of Erectile Dysfunction In Mexico

Apricus Biosciences Announces Approval Of Vitaros® For The Treatment Of Erectile Dysfunction In Mexico

Ferring Plans to Launch in Mexico and Argentina During the Second Quarter 2017

Apricus Biosciences Announces The Launch Of Vitaros® For The Treatment Of Erectile Dysfunction In Lebanon By Elis Pharmaceuticals

Apricus Biosciences Announces The Launch Of Vitaros® For The Treatment Of Erectile Dysfunction In Lebanon By Elis Pharmaceuticals

Continued Commercial Expansion in the Middle East Expected to Increase Royalty Revenue for Apricus

Apricus Biosciences Receives Nasdaq Compliance Notice

Apricus Biosciences Receives Nasdaq Compliance Notice

Company Intends to Request Hearing